PROPHASE LABS, INC. ANNOUNCES SPECIAL CASH DIVIDEND
21 November 2019 - 8:15AM
ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com), a
vertically integrated manufacturer, marketer and distributor of a
diversified range of over-the-counter dietary supplements
(“ProPhase” or “Company”), announced today that its Board of
Directors has declared a special cash dividend in the amount of
$0.25 per share on its common stock, payable on December 12, 2019
to stockholders of record as of December 3, 2019.
“We are very pleased to be able to reward our
stockholders with this special cash dividend. This dividend
provides an immediate benefit to our stockholders, while allowing
us to remain well positioned for future growth with ample liquidity
for strategic opportunities that may arise,” said Ted Karkus,
Chairman and Chief Executive Officer of ProPhase.
Mr. Karkus continued, “I would like to
personally thank our stockholders for their unwavering support and
loyalty.”
In connection with the special cash dividend,
the Compensation Committee of the Board of Directors has approved a
proportionate and equitable adjustment to the stock option granted
to Mr. Karkus on February 23, 2018, as required under the 2018
Stock Incentive Plan, subject to the vesting requirements of the
stock option. The adjustment will become effective as of December
12, 2019, the date the special cash dividend is to be paid.
About the Company
We are a vertically integrated and diversified
branding, marketing and technology company with deep experience
with over-the-counter (“OTC”) consumer healthcare products, dietary
supplements and other remedies. We are engaged in the research,
development, manufacture, distribution, marketing and sale of OTC
consumer healthcare products, dietary supplements and other
remedies in the United States. This includes the development and
marketing of dietary supplements under the TK
Supplements® brand.
In addition, the Company also continues to
actively pursue acquisition opportunities for other companies,
technologies and products inside and outside the consumer products
industry. For more information visit us at
www.ProPhaseLabs.com.
Investor Contact
Ted Karkus, Chairman and CEOProPhase Labs,
Inc.(267) 880-1111
ProPhase Labs (NASDAQ:PRPH)
Historical Stock Chart
From Apr 2024 to May 2024
ProPhase Labs (NASDAQ:PRPH)
Historical Stock Chart
From May 2023 to May 2024